Market Place
Sourcing Support
DARZALEX SC Regimens Improve MRD Negativity & Survival in Myeloma
09 Dec 2024 //
GLOBENEWSWIRE
Darzalex SC Reduces Risk of Progression in Smouldering Myeloma
08 Dec 2024 //
GLOBENEWSWIRE
DARZALEX FASPRO® Improves MRD Negativity in Multiple Myeloma
08 Dec 2024 //
PR NEWSWIRE
Darzalex Faspro Reduces Risk In Smoldering Multiple Myeloma
08 Dec 2024 //
PR NEWSWIRE
J&J angles Darzalex for first move into early-stage myeloma
09 Nov 2024 //
FIERCE PHARMA
J&J Submits Darzalex Faspro for High-Risk Myeloma Approval
08 Nov 2024 //
GLOBENEWSWIRE
Halozyme Update On Licensee Co-Formulation Patent Hearing
24 Oct 2024 //
PR NEWSWIRE
Cancer drug sales lift J&J past Wall Street expectations
15 Oct 2024 //
REUTERS
Genmab Announces Net Sales of Darzalex for Third Quarter of 2024
15 Oct 2024 //
GLOBENEWSWIRE
J&J Submits DARZALEX SC Quadruplet For Multiple Myeloma To EMA
10 Oct 2024 //
GLOBENEWSWIRE
J&J Files For FDA Approval Of DARZALEX FASPRO Regimen
30 Sep 2024 //
PR NEWSWIRE
TALVEY & DARZALEX Show Durable Responses In Myeloma Patients
27 Sep 2024 //
GLOBENEWSWIRE
SciBase announces sale of Nevisense to NIH (US)
27 Sep 2024 //
PR NEWSWIRE
Darzalex Based Maintenance Shows Deep Responses In Multiple Myeloma
27 Sep 2024 //
PR NEWSWIRE
Darzalex SC Formulation Improves Negativity For Multiple Myeloma
27 Sep 2024 //
GLOBENEWSWIRE
Oncocyte`s VitaGraft Kidney Used In New Case Series Study
12 Aug 2024 //
GLOBENEWSWIRE
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024
17 Jul 2024 //
GLOBENEWSWIRE
J&J beats Wall St estimates on strong drug sales ahead of Stelara competition
17 Jul 2024 //
REUTERS
Legend Biotech Reports Positive OS Results From CARTITUDE-4 Trial
02 Jul 2024 //
GLOBENEWSWIRE
GSK readopts £3B peak sales estimate for myeloma ADC Blenrep
18 Jun 2024 //
FIERCE PHARMA
ASCO: Sanofi`s Sarclisa looks to step out of J&J`s myeloma shadow
04 Jun 2024 //
FIERCE PHARMA
Johnson & Johnson 1Q Results
20 May 2024 //
CONTRACT PHARMA
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
16 Apr 2024 //
GLOBENEWSWIRE
GSK details combo data that could bring Blenrep back to life
06 Feb 2024 //
FIERCE PHARMA
J&J submits sBLA to U.S. FDA seeking approval of DARZALEX FASPRO
30 Jan 2024 //
PR NEWSWIRE
DARZALEX shows significant improvement in multiple myeloma
12 Dec 2023 //
PR NEWSWIRE
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
12 Dec 2023 //
FIERCE PHARMA
AbbVie`s Humira, J&J`s Darzalex top ICER`s annual price-hike list
11 Dec 2023 //
FIERCE PHARMA
Daratumumab-Based Quadruplets Show Efficacy in Newly Diagnosed Myeloma
29 Sep 2023 //
ONCLIVE
CD38/48 Upregulation With Tazemetostat May Overcome Daratumumab Resistance
29 Sep 2023 //
ONCLIVE
Genmab Announces Net Sales of DARZALEX (daratumumab) for Second Quarter of 2023
20 Jul 2023 //
GLOBENEWSWIRE
With Darzalex thriving, J&J increases revenue guidance for 2023
20 Jul 2023 //
FIERCE PHARMA
Janssen`s Biologic Darzalex (Daratumumab) Receives Approval in the U.S.
19 Jan 2023 //
FDA
Janssen Presents Efficacy Analyses from MAIA Study Showing Results of DARZALEX
12 Dec 2022 //
PRNEWSWIRE
Janssen Presents Efficacy and Subgroup Analyses from MAIA Study of DARZALEXÂ
12 Dec 2022 //
GLOBENEWSWIRE
Janssen Presents Data from MajesTEC-2 Trial of TECVAYLI with DARZALEX
10 Dec 2022 //
GLOBENEWSWIRE
Janssen Presents Data from MajesTEC-2 Trial of TECVAYLI with DARZALEX FASPRO
10 Dec 2022 //
PRNEWSWIRE
Janseen` Biologic Darzalex (Daratumumab) Receives Approval in the U.S.
01 Nov 2022 //
FDA
Janssen reports Phase II data for Darzalex-RVd to treat multiple myeloma
29 Aug 2022 //
CLINICALTRIALSARENA
SMC accepts first licensed treatment for newly diagnosed AL amyloidosis
09 Aug 2022 //
PHARMAFILE
J&J`s switch from IV to subcut Darzalex is 85% complete in US
25 Jul 2022 //
FIERCEPHARMA
Genmab Announces Net Sales of DARZALEX (daratumumab) for First Quarter of 2022
19 Apr 2022 //
GLOBENEWSWIRE
J&J can reduce Darzalex royalty payments, a tribunal voted
09 Apr 2022 //
FIERCEPHARMA
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2021
25 Jan 2022 //
GLOBENEWSWIRE
NICE recommends combination treatment for patients with multiple myeloma
24 Dec 2021 //
PHARMAFILE
New Clinical and Real-World Data Support Use of DARZALEX in MM
11 Dec 2021 //
BUSINESSWIRE
FDA Grants Approval to Janssen`s DARZALEX FASPRO + Carfilzomib & Dexamethasone
01 Dec 2021 //
PRNEWSWIRE
J&J to divide into consumer health and pharmaceutical businesses
15 Nov 2021 //
PHARMACEUTICAL-TECHNOLOGY
Non-genetic amyloidosis lives again, thanks to Darzalex and Astra
29 Sep 2021 //
EVALUATE
NICE rebuffs J&J`s Darzalex combo for 1L multiple myeloma
27 Aug 2021 //
FIERCEPHARMA
NICE rejects combination treatment for multiple myeloma
26 Aug 2021 //
PHARMA FILE
Indapta Therapeutics Announces New Preclinical Data for Proprietary G-NK Cells
10 Aug 2021 //
BUSINESSWIRE
DARZALEX SC Formulation Approved for Systemic Light Chain Amyloidosis
23 Jun 2021 //
BUSINESSWIRE
Janssen Receives European Marketing Authorizations for DARZALEX
22 Jun 2021 //
PRNEWSWIRE
Janssen has Received European Marketing Authorizations for DARZALEX
22 Jun 2021 //
GLOBENEWSWIRE
Five-Year Positive Data for Newly Diagnosed Multiple Myeloma: Presented at EHA
18 Jun 2021 //
FIRSTWORDPHARMA
